The Genetic Endometriosis Research Study is being conducted by Juneau Biosciences, a Utah-based company that is working to identify the genetic variations that predispose women to endometriosis. This type of research requires tens of millions of dollars and is enabled by a number of private investors. The company’s core team has extensive knowledge and experience in biomedical research, disease gene discovery, and molecular diagnostics. Juneau’s researchers hope to use the information from this study to develop a noninvasive diagnostic, treatment, and perhaps even a cure for endometriosis.